Page 14 - Sohini Das

Amazon enters India's $15 bn diagnostics market with at-home testing

Amazon enters India's $15 bn diagnostics sector with at-home test collection, digital reports and integrated health services through Amazon Medical across six cities

Decision on merger with Biocon Biologics soon, says Siddharth Mittal

We are talking about the GLP-1 opportunity and our strong franchise in insulins. There is a huge demand in the global diabetes-obesity segment, said Siddharth Mittal

Tata Motors expects to achieve 30% EV penetration ahead of target: Chandra

Looking for alternative sourcing for Rare earth magnets and focussing on right level of inventory, Chandra says

Pharma manufacturing tends to cause AMR in communities: Nick Voulvoulis

Changes are required both in manufacturing practices as well as in regulatory oversight, says Voulvoulis

Abbott, MSD join hands to distribute key diabetic drug across India

Abbott to distribute MSD's sitagliptin portfolio-Januvia, Janumet, Janumet XR-in India, targeting deeper reach in the ₹950-1,000 crore diabetes drug segment

India's CV industry quietly begins shift to hydrogen-powered vehicles

Ashok Leyland, Tata Motors and Daimler lead India's shift to hydrogen-powered commercial vehicles as pilot trials expand under the National Green Hydrogen Mission

Passenger vehicle dispatches dip marginally in May, two-wheelers edge up

Passenger vehicle dispatches were down by 0.8 per cent to 344,656 units

Ultraviolette revs up electric vehicle play with 2 launches in Paris

F77 MACH 2 and SuperStreet mark Ultraviolette's EU entry; India-based electric motorcycle maker eyes Germany, France, Italy and more in phase one

On guard, to keep waves at bay: No rush to stockpile Covid vaccines

The virus may have lost its 'bite', but is still highly transmissible, as experts point out

Sun Pharma starts succession plan; Ganorkar succeeds Shanghvi as MD

Dilip Shanghvi to remain executive chairman while Ganorkar takes charge as MD from September 1 and Aalok Shanghvi is given additional charge of North America business

Skoda aims automatics to form 70% of India sales, eyes 3% market share

Skoda India sees growth in automatics and network expansion as key drivers to reach 3 per cent market share, with EV plans and a new SUV also in the works

Mercedes-Benz sees surge in customisation; luxury EV sales up 66%

Mercedes-Benz India launches collector's AMG G 63 as demand for personalisation grows; luxury EV sales rise 66 per cent in Jan-May, driven by new-age preferences

Automakers gear up to roll out EVs without rare earth magnets by FY27

While companies remain tight-lipped about the development, most acknowledge that such a transition is essential to align with the rapid growth of the EV sector

Pharma body seeks rethink on entry curbs of MRs in govt hospitals

Indian Pharmaceutical Alliance warns that the DGHS ban on medical representatives may affect public health, slow innovation and result in pharma sector job losses

Renalyx launches smart dialysis unit RxT21, plans ₹800 crore boost

Renalyx Health Systems launches AI-enabled dialysis machine RxT21 with real-time monitoring at ₹6.7 lakh, plans to scale production and expand into global markets

TaMo eyes 40% CV, 16% PV market share; EV biz hits Ebitda breakeven

Tata Motors targets 40% share in CVs and 16% in PVs by FY27, plans major EV investments and demerger of vehicle businesses by end-2025

AC norms bring chills to truck segment; to pinch pockets by up to 2%

Truck sales dipped in May 2025 as AC cabins became mandatory for all new medium and heavy vehicles, with OEMs backing the rule and fleet owners flagging cost and workforce concerns

From showrooms to shelves, India likely to witness consumption uptick

Godrej Consumer Products also expects demand to rise for categories like personal care and home care

Rare earth crisis: Indian companies hopeful as global panic sets in

With China tightening rare earth exports, Indian firms eye domestic incentives and stockpiling, as global automakers and medical device makers face rising supply fears

Wockhardt's novel antibiotic Zaynich eyes $9 billion global market

Company to launch Zaynich in India this fiscal; sees $7 bn market in US and EU and ₹17,000 crore in India; USFDA, EU filings underway for FY26